Enikö Simkovics
University of Debrecen
4 Papers
131 Citations
Enikö Simkovics is an academic researcher from University of Debrecen. The author has contributed to research in topics: Framingham Risk Score & Pharmacogenomics. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Accelerated atherosclerosis in rheumatoid arthritis
Zoltán Szekanecz,György Kerekes,Henriett Dér,Zsuzsa Sándor,Zoltán Szabó,Anikó Végvári,Enikö Simkovics,Lilla Soós,Agnes Szentpetery,Timea Besenyei,Gabriella Szücs,Sándor Szántó,László Tamási,Gyula Szegedi,Yehuda Shoenfeld,Pál Soltész +15 more
TL;DR: In this paper, the early determination of common carotid intima-media thickness (ccIMT), flow-mediated vasodilation (FMD), and nitroglycerine-medication-induced vascular dysfunction (NMD) may be useful to determine atherosclerosis and endothelial dysfunction.
125
Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?
Éva Szekanecz,Zsuzsa Sándor,Péter Antal-Szalmás,Lilla Soós,Gabriella Lakos,Timea Besenyei,Agnes Szentpetery,Enikö Simkovics,János Szántó,Emese Kiss,Alisa E. Koch,Zoltán Szekanecz +11 more
TL;DR: Levels of TAAs including CEA, CA15‐3, CA72‐4, CA125, and CA19‐9, and neuron‐specific enolase were assessed by immunoassay in the sera of 75 patients with RA and 50 age‐ and sex‐matched healthy controls.
Pharmacogenetics and pharmacogenomics in rheumatology
Zoltán Szekanecz,Bertalan Meskó,Szilárd Póliska,Andrea Váncsa,Szilvia Szamosi,Edit Végh,Enikö Simkovics,Judit Laki,Júlia Kurkó,Júlia Kurkó,Timea Besenyei,Timea Besenyei,Katalin Mikecz,Tibor T. Glant,Laszlo Nagy +14 more
TL;DR: Focused studies carried out in larger patient cohorts, using pre-selected genes, may be needed in order to determine the future of pharmacogenetics and pharmacogenomics as tools for personalized medicine in rheumatology.
26
Myelofibrosis in systemic lupus erythematosus.
TL;DR: Treatment with immunosuppressive and colony stimulating factor led to slow but complete regeneration of the bone marrow and subsequently to an improved haematological status, and the patient was spared bone marrow transplantation.